Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study
- PMID: 20167919
- PMCID: PMC2847685
- DOI: 10.1161/STROKEAHA.109.570044
Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study
Abstract
Background and purpose: White matter hyperintensities and MRI-defined brain infarcts (BIs) have individually been related to stroke, dementia, and mortality in population-based studies, mainly in older people. Their significance in middle-aged community-dwelling persons and the relative importance of these associations remain unclear. We simultaneously assessed the relation of white matter hyperintensities and BI with incident stroke, mild cognitive impairment, dementia, and mortality in a middle-aged community-based cohort.
Methods: A total of 2229 Framingham Offspring Study participants aged 62+/-9 years underwent volumetric brain MRI and neuropsychological testing (1999 to 2005). Incident stroke, dementia, and mortality were prospectively ascertained and for 1694 participants in whom a second neuropsychological assessment was performed (2005 to 2007), incident mild cognitive impairment was evaluated. All outcomes were related to white matter hyperintensities volume (WMHV), age-specific extensive WMHV and BI adjusting for age and gender.
Results: Extensive WMHV and BI were associated with an increased risk of stroke (hazard ratio [HR]=2.28, 95% CI: 1.02 to 5.13; HR=2.84, 95% CI: 1.32 to 6.10). WMHV, extensive WMHV, and BI were associated with an increased risk of dementia (HR=2.22, 95% CI: 1.32 to 3.72; HR=3.97, 95% CI: 1.10 to 14.30; HR=6.12, 95% CI: 1.82 to 20.54) independently of vascular risk factors and interim stroke. WMHV and extensive WMHV were associated with incident amnestic mild cognitive impairment in participants aged > or = 60 years only (OR=2.47, 95% CI: 1.31 to 4.66 and OR=1.49, 95% CI: 1.14 to 1.97). WMHV and extensive WMHV were associated with an increased risk of death (HR=1.38, 95% CI: 1.13 to 1.69; HR=2.27, 95% CI: 1.41 to 3.65) independent of vascular risk factors and of interim stroke and dementia.
Conclusions: In a large community-based sample of middle-aged adults, BI predicted an increased risk of stroke and dementia independent of vascular risk factors. White matter hyperintensities portended an increased risk of stroke, amnestic mild cognitive impairment, dementia, and death independent of vascular risk factors and interim vascular events.
Conflict of interest statement
Figures




Comment in
-
What do white matter hyperintensities really represent?Stroke. 2010 Apr;41(4):574. doi: 10.1161/STROKEAHA.109.574442. Epub 2010 Feb 25. Stroke. 2010. PMID: 20185776 No abstract available.
References
-
- Wong TY, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP, Hubbard LD, Mosley TH. Cerebral white matter lesions, retinopathy, and incident clinical stroke. Jama. 2002;288:67–74. - PubMed
-
- Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke. 2003;34:1126–1129. - PubMed
-
- Kuller LH, Longstreth WT, Jr, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ., Jr White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke. 2004;35:1821–1825. - PubMed
-
- Bokura H, Kobayashi S, Yamaguchi S, Iijima K, Nagai A, Toyoda G, Oguro H, Takahashi K. Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study. J Stroke Cerebrovasc Dis. 2006;15:57–63. - PubMed
-
- Bernick C, Kuller L, Dulberg C, Longstreth WT, Jr, Manolio T, Beauchamp N, Price T. Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology. 2001;57:1222–1229. - PubMed
Publication types
MeSH terms
Grants and funding
- N01-HC-25195/HC/NHLBI NIH HHS/United States
- R01 NS017950/NS/NINDS NIH HHS/United States
- R01 AG016495/AG/NIA NIH HHS/United States
- AG033193/AG/NIA NIH HHS/United States
- AG08122/AG/NIA NIH HHS/United States
- R01 AG008122/AG/NIA NIH HHS/United States
- AG031287/AG/NIA NIH HHS/United States
- R01 NS17950/NS/NINDS NIH HHS/United States
- N01 HC025195/HC/NHLBI NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- R01 AG033193/AG/NIA NIH HHS/United States
- K23 AG038444/AG/NIA NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
- R01 AG16495/AG/NIA NIH HHS/United States
- R01 AG031287/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical